Literature DB >> 1519477

Myasthenia gravis in Hong Kong Chinese. 2. Paediatric disease.

V Wong1, B R Hawkins, Y L Yu.   

Abstract

In a study covering 85% of the population of Hong Kong, 39% of all myasthenia gravis (MG) patients, i.e. 103 individuals (54 girls and 49 boys) were found to have had MG with onset before puberty. Two patients had transient neonatal MG, 20 had early onset juvenile MG and 81 had late onset juvenile MG. Restricted ocular MG occurred in 71% of patients and the remainder had generalised MG. The median age at onset was 4 years. Complete remission occurred in 34 patients (34%), a good response in 14 (14%), and fair response in 32 (32%). The clinical course remained static in 16 patients (16%) and 3 patients deteriorated. Two patients died, 1 with myasthenic crisis and the other with cholinergic crisis. All patients, except 2 with neonatal MG, were initially treated with anticholinesterase, but 24% also required steroid therapy. Thymectomy was performed for 12 patients, of whom 5 (42%) showed marked improvement. Thymic histology was normal in 3, showed hyperplasia in 6, non-invasive thymoma in 1 and involution in 2. The most commonly associated disease was Graves' disease which occurred in 7 patients (7%).

Entities:  

Keywords:  Adolescents; Age Factors; Asia; Biology; Child; Comparative Studies; Congenital Abnormalities; Cross-cultural Comparisons; Demographic Factors; Developing Countries; Diseases; Eastern Asia; Follow-up Studies; Hong Kong; Incidence; Infant; Measurement; Neonatal Diseases And Abnormalities; Neurologic Effects; Ophthalmological Effects; Physiology; Population; Population Characteristics; Research Methodology; Retrospective Studies; School Age Population; Studies; Treatment; Youth

Mesh:

Substances:

Year:  1992        PMID: 1519477     DOI: 10.1111/j.1600-0404.1992.tb08056.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  6 in total

Review 1.  Juvenile myasthenia: diagnosis and treatment.

Authors:  B Anlar
Journal:  Paediatr Drugs       Date:  2000 May-Jun       Impact factor: 3.022

2.  Strabismus surgery and long-term visual outcomes in patients with preadolescent onset ocular myasthenia gravis.

Authors:  Jinu Han; So Young Han; Sueng-Han Han; Jong Bok Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-11-16       Impact factor: 3.117

3.  Long-term outcome of 424 childhood-onset myasthenia gravis patients.

Authors:  Mengcui Gui; Xuan Luo; Jing Lin; Yue Li; Min Zhang; Xiaofan Zhang; Mingshan Yang; Wei Wang; Bitao Bu
Journal:  J Neurol       Date:  2015-01-15       Impact factor: 4.849

4.  The MGTX experience: challenges in planning and executing an international, multicenter clinical trial.

Authors:  Inmaculada B Aban; Gil I Wolfe; Gary R Cutter; Henry J Kaminski; Alfred Jaretzki; Greg Minisman; Robin Conwit; John Newsom-Davis
Journal:  J Neuroimmunol       Date:  2008-09-15       Impact factor: 3.478

5.  Refractory myasthenia gravis - clinical profile, comorbidities and response to rituximab.

Authors:  Sreenivasa Rao Sudulagunta; Mona Sepehrar; Mahesh Babu Sodalagunta; Aravinda Settikere Nataraju; Shiva Kumar Bangalore Raja; Deepak Sathyanarayana; Siddharth Gummadi; Hemanth Kumar Burra
Journal:  Ger Med Sci       Date:  2016-10-13

Review 6.  The Epidemiology and Phenotypes of Ocular Manifestations in Childhood and Juvenile Myasthenia Gravis: A Review.

Authors:  Jeannine M Heckmann; Tarin A Europa; Aayesha J Soni; Melissa Nel
Journal:  Front Neurol       Date:  2022-02-23       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.